Cargando…

Antifungal Activity of Plantago lanceolata and Sida ovata Leaf Extracts against Dermatomycotic Fungi

Plantago lanceolata and Sida ovata have been used as medicinal plants for centuries to cure numerous diseases. This study aimed to evaluate antifungal activity of P. lanceolata and S. ovata leaf extracts against dermatomycotic fungi. Crude extracts from leaves of both plants were prepared using meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiru, Tamene Milkessa, Getahun, Muluneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423090/
https://www.ncbi.nlm.nih.gov/pubmed/37576453
http://dx.doi.org/10.1155/2023/9957892
Descripción
Sumario:Plantago lanceolata and Sida ovata have been used as medicinal plants for centuries to cure numerous diseases. This study aimed to evaluate antifungal activity of P. lanceolata and S. ovata leaf extracts against dermatomycotic fungi. Crude extracts from leaves of both plants were prepared using methanol and ethyl acetate. Phytochemical screening of both plants leaves was performed. Antifungal activity of crude extracts was evaluated against three dermatomycotic fungi (Candida albicans, Malassezia furfur, and Malassezia globosa). In addition, minimum inhibitory concentration (MIC) of the extracts was determined by microbroth dilution method. Maximum inhibition zone of 32.00 ± 11.64 mm was exhibited when combined ethyl acetate extract of both plants was applied against M. globosa. Best effect of MIC was demonstrated by ethyl acetate extract against most tested dermatomycotic fungi. Average MIC of ethyl acetate and methanol extracts ranged as follows: (0.19 ± 0.00 to 0.65 ± 0.00 mg/mL and 0.19 ± 0.00 to 0.52 ± 0.22 mg/mL) and (0.65 ± 0.22 to 1.56 ± 0.00 mg/mL and 0.19 ± 0.00 to 0.52 ± 0.00 mg/mL), respectively. Their synergistic effect was better than the effect of individual plant leaf extract. Minimum fungicidal concentration (MFC) values varied across the fungal pathogens when extracts from both plants and their combinations were used. The findings from the current study support the traditional use of P. lanceolata and S. ovata against dermatomycotic fungal infections, which could potentially be exploited for the treatment of superficial infection in humans.